THE GAZETTE OF INDIA[MINISTRY OF HEALTH AND FAMILY WELFARE]

                                 MINISTRY OF HEALTH AND FAMILY WELFARE

                                             [ Department of Health and Family Wealfare]

                                                             NOTIFICATION

                                             New Delhi,the 10th Feruary,2011

            G.S.R. 82{E}--Where as the Central Government is satisfied that the us of following drugs is likely to involve certain risks to human beings and whereas safar alternatives to the said drugs are available,

             And whereas theCentral Government is satisfied that it is necessary and expedient to prohibit the manufacture.sale and distribution of the said drugs in public interest.

LIST OF NOT OF STANDARD QUALITY DRUGS

THE FOLLOWING DRUGE ARE NOT OF STANDARD QUALITY [14/02/2011-20/02/2011]

Sl.No	Name of the Product	B.No.	D/M D/E	Mfd.by
01	MAXCAL TAB.[calcium carbonate Magnesium Hydroxide,zinc & vitamin D3 Tablets]	MMT-037	12/09 11/11	M/S Stride Organics Pvt.Ltd,Khasra No 143.Rajapur.Roorkee-247667
02	URAMINE,chlorpheniramine Maleate Injection I.P.	URM-030/30	05/10 04/12	M/S Unison Pharmaceuticals,Plot No.124 EPIP,Indl.Area Phase-I,Jharmajri,Baddi[H.P]

A LARGE NUMBERS TURNED TOWARDS............................

IN LARGE NUMBERS,THE PEOPLES FROM ALL COMMUNITY,STUDENTS OF VARIOUS SCHOOLS,COLLEGES,BUSINESS PEOPLES OF VARIOUS TRADE ASSOCIATIONS PARTICIPATED IN HUGE HUMAN CHAIN RALLY FOR BELGAUM VISION 2040.THIS MEGA EVENT IS ORGANISED BY BELGAUM SOUTH MLA SHRI ABHAY PATIL.

New ingredients in drug? Can't retail under old name Read more

NEW DELHI, 16 FEB: The government will no longer allow popular drugs to be sold under the same name in case their vital ingredients have been changed. Pharmaceutical companies will now have to also change the brand name of the drug if there is a change in their active ingredients. This was decided by the Drug Controller General of India (DCGI), Dr Surinder Singh, in a specially called meeting of the country's Drugs Consultative Committee (DCC) on Tuesday.

Two drugs banned for their side-effects

NEW DELHI, 19 FEB: India's Drug Technical Advisory Board (DTAB) has decided to ban two controversial drugs - Gatifloxacine and Tegaserod - because of their side-effects. The decision was taken by DTAB's sub-committee headed by Dr Y K Gupta from AIIMS which met on Thursday. DTAB, however, could not make up its mind on the third controversial drug Deanxit and said, "More data is needed on the drug's side-effects."